DE69119185D1 - Derivate von Carboxymethyl-Chitin und ihre Verwendung - Google Patents

Derivate von Carboxymethyl-Chitin und ihre Verwendung

Info

Publication number
DE69119185D1
DE69119185D1 DE69119185T DE69119185T DE69119185D1 DE 69119185 D1 DE69119185 D1 DE 69119185D1 DE 69119185 T DE69119185 T DE 69119185T DE 69119185 T DE69119185 T DE 69119185T DE 69119185 D1 DE69119185 D1 DE 69119185D1
Authority
DE
Germany
Prior art keywords
derivatives
carboxymethyl chitin
chitin
carboxymethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69119185T
Other languages
English (en)
Other versions
DE69119185T2 (de
Inventor
Masayoshi Kojima
Hiroyuki Komazawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Holdings Corp
Original Assignee
Fuji Photo Film Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3066156A external-priority patent/JP2662830B2/ja
Application filed by Fuji Photo Film Co Ltd filed Critical Fuji Photo Film Co Ltd
Publication of DE69119185D1 publication Critical patent/DE69119185D1/de
Application granted granted Critical
Publication of DE69119185T2 publication Critical patent/DE69119185T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69119185T 1990-10-26 1991-10-24 Derivate von Carboxymethyl-Chitin und ihre Verwendung Expired - Fee Related DE69119185T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP28949190 1990-10-26
JP33371890 1990-11-30
JP3066156A JP2662830B2 (ja) 1990-10-26 1991-03-29 Ｃｍ−キチン誘導体およびその用途

Publications (2)

Publication Number Publication Date
DE69119185D1 true DE69119185D1 (de) 1996-06-05
DE69119185T2 DE69119185T2 (de) 1996-08-14

Family

ID=27299034

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69119185T Expired - Fee Related DE69119185T2 (de) 1990-10-26 1991-10-24 Derivate von Carboxymethyl-Chitin und ihre Verwendung

Country Status (3)

Country Link
US (1) US5298488A (de)
EP (1) EP0482649B1 (de)
DE (1) DE69119185T2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6017877A (en) * 1990-04-06 2000-01-25 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
DE69332203T2 (de) * 1992-10-02 2003-05-28 Diatide, Inc. Multimerische mehrzweckwirkstoffe gegen thrombose
US5459257A (en) * 1993-01-11 1995-10-17 Dainippon Ink And Chemicals, Inc. Sulfated oligoglycoside acylate and antiviral agent containing the same as active ingredient
US5665702A (en) * 1995-06-06 1997-09-09 Biomeasure Incorporated Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
US6479457B2 (en) 1995-06-06 2002-11-12 Kinerton Limited Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
JPH09143199A (ja) * 1995-11-17 1997-06-03 Nippon Chem Res Kk 血小板第４因子の製造方法
US7192984B2 (en) * 1997-06-17 2007-03-20 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use as dermal fillers
US6869938B1 (en) 1997-06-17 2005-03-22 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use in reducing adhesions
US20040096422A1 (en) * 1997-06-17 2004-05-20 Schwartz Herbert E. Compositions of polyacids and polyethers and methods for their use in reducing pain
US20050074495A1 (en) * 1997-06-17 2005-04-07 Fziomed, Inc. Compositions of polyacids and methods for their use in reducing adhesions
US6566345B2 (en) 2000-04-28 2003-05-20 Fziomed, Inc. Polyacid/polyalkylene oxide foams and gels and methods for their delivery
CA2407235A1 (en) * 2000-04-28 2001-11-08 Fziomed, Inc. Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326532A (en) * 1980-10-06 1982-04-27 Minnesota Mining And Manufacturing Company Antithrombogenic articles
US4666884A (en) * 1984-04-10 1987-05-19 New England Deaconess Hospital Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls
US4988621A (en) * 1985-05-24 1991-01-29 La Jolla Cancer Research Foundation Peptides in cell detachment and aggregation
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors
US4952562A (en) * 1989-09-29 1990-08-28 Rorer Pharmaceutical Corporation Anti-thrombotic peptides and pseudopeptides

Also Published As

Publication number Publication date
EP0482649B1 (de) 1996-05-01
US5298488A (en) 1994-03-29
DE69119185T2 (de) 1996-08-14
EP0482649A2 (de) 1992-04-29
EP0482649A3 (en) 1992-11-19

Similar Documents

Publication Publication Date Title
DE69424853D1 (de) Morphinan-derivate und ihre medizinische verwendung
DE69133471D1 (de) Azolderivate und ihre Verwendung als Inhibitoren von Superoxidradikalen
DE69119185D1 (de) Derivate von Carboxymethyl-Chitin und ihre Verwendung
DE69124416D1 (de) Wässrige Gelzusammensetzungen und ihre Verwendung
DE69638056D1 (de) Azeotropähnliche zusammensetzungen und ihre verwendung
DE3770085D1 (de) Cyclodextrinclathrate von carbacyclinderivaten und ihre verwendung als arzneimittel.
FI943718A0 (fi) Piperatsiini- ja piperadiinijohdannaisia ja niiden käyttö antipsykoottisina aineina
FI970111A0 (fi) Helico-bakteerin vastaisia atsolonien urea- ja tioureajohdannaisia
DE3888466D1 (de) 6-Arylaminomethylchinolin-Derivate und ihre Verwendung als Antitumorwirkstoff.
DE68923860D1 (de) Derivate von Alkoholen und Ethern.
DE69123162D1 (de) Ascorbatoxidase und ihre Verwendung
DE69420095D1 (de) Derivate von Polysacchariden, ihre Herstellung und Verwendung
ATE168107T1 (de) 4-benzoylisoxazole-derivate und ihre verwendung als herbizide
DE69332815D1 (de) Polyglyzidyl-Äthern und ihre Verwendung
DE3854981D1 (de) 1-Pyrrolidinacetamid-Derivate und ihre Verwendung
DE69500209D1 (de) Reinigende kosmetische Zusammensetzungen und ihre Verwendung
ATE260258T1 (de) Substituierte isochinoline derivate und ihre verwendung als anticonvulsiva
ATA125788A (de) Neue derivate von 5-aminomethyl-2-furanmethanol, ihre herstellung und verwendung
DE69521174D1 (de) Anthrachinonderivate mit antitumorwirkung und ihre verwendung
FI935654A0 (fi) Kondenserade heterocykliska foereningar, deras framstaellning och anvaendning
ATE141054T1 (de) Verwendung von hyaluronsäure und derivate zur vorbeugung arterieller restenose
DE69024524D1 (de) Substituierte Tetrahydroindanderivate und ihre Verwendung als Zwischenprodukte
DE69203699D1 (de) Arylindazolderivate und ihre Verwendung.
ATA125688A (de) 1-amino-2-(phenoxypropylamino)-1-cyclobuten-3,4 dionderivate und ihre verwendung
DE69802908D1 (de) Salicylsäure - sphingoidbase derivate und ihre verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee